Beam Therapeutics Inc. (NASDAQ:BEAM) H.C. Wainwright 27th Annual Global Investment Conference September 8, 2025 10:30 AM EDT
Company Participants
John Evans – CEO & Director
Conference Call Participants
Patrick Trucchio – H.C. Wainwright & Co, LLC, Research Division
Unknown Attendee
Presentation
Patrick Trucchio
MD of Equity Research & Senior Healthcare Analyst
Great. Good morning, everyone, and thank you for joining H. C. Wainwright’s 27th Annual Global Investment Conference, September 8 to September 10, 2025. My name is Patrick Trucchio. I’m the senior healthcare at H. C. Wainwright. It’s my pleasure to introduce our next company, and next speaker. It’s my pleasure to welcome Beam Therapeutics, a biotechnology company, leveraging its fully integrated precision genetic medicine platform to bring lifelong cures to patients suffering from serious diseases.
Beam’s suite of gene editing technology is anchored by base editing, a proprietary technology, that is designed to enable precise predictable and efficient single-based changes at targeted genomic sequences without making double-stranded breaks in the DNA. And with that, it’s my pleasure to introduce the CEO, John Evans. Welcome to the fireside chat today.
John Evans
CEO & Director
Great to be here. Thank you.
Question-and-Answer Session
Patrick Trucchio
H.C. Wainwright & Co, LLC, Research Division
So first, maybe you can briefly introduce Beam’s base editing platform, how it differs from first-generation gene editing and what it enables clinically?
John Evans
CEO & Director
Great. So Beam is working on a next-generation version of CRISPR gene editing. It’s called base editing. And with gene editing in general and CRISPR specifically, we have the amazing ability to target the genome very precisely. We can choose one spot across 3 billion different letters of your genes, where there’s an error and go in and try to fix it. What is different about what we do is that once we get to that target site, we
#Beam #Therapeutics #BEAM #H.C #Wainwright #27th #Annual #Global #Investment #Transcript